Author : adminDate : 2023-03-07 09:56

PSMC emerges as core of HLB Group interested in CAR-T drugs

PSMC will change its name to HLB innoVation at a shareholder meeting next month to emerge as the HLB Group’s key unit in developing CAR-T (chimeric antigen receptor-T cell) treatments.

Please refer to the following website for further details: